Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00439686 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of ZIO-201 in Advanced Sarcoma

StatusCompleted
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv10
  2. Primary endpoint revised Enrollment target: 53 to 54 · Secondary endpoints: 1 to 2 · Study arms: 1 to 2v9 Show all 4 changesShow less
    • Enrollment target: 53 to 54
    • Secondary endpoints: 1 to 2
    • Study arms: 1 to 2

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date: Jun 2008 to Jan 16, 2008 Completion date: Dec 2013 to Jan 16, 2008 · Start date: Feb 2006 to Feb 21, 2006v8 Show all 3 changesShow less
    • Completion date: Dec 2013 to Jan 16, 2008
    • Start date: Feb 2006 to Feb 21, 2006
  4. Primary completion date: Mar 2008 to Jun 2008 Completion date: Mar 2008 to Dec 2013v7 Show all 2 changesShow less
    • Completion date: Mar 2008 to Dec 2013
  5. Enrollment target: estimated 40 to confirmed 53v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Active, Not Recruiting to Completedv5
  2. 2 versions Re-verified since Aug 22, 2008, no change to tracked fieldsv3-v4
  3. Trial status: Recruiting to Active, Not Recruiting Enrollment target: 40 · Study sites: 1 to 2 · Primary and study completion dates: Mar 2008 · 2 morev2 Show all 6 changesShow less
    • Enrollment target: 40
    • Study sites: 1 to 2
    • Primary and study completion dates: Mar 2008
    • Start date: Feb 2006
    • Study arms: 0 to 1
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.
Trial Details
NCT Number NCT00439686
Lead Sponsor Alaunos Therapeutics
Conditions Advanced Sarcoma
Enrollment 54 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov